Analyst stock forecast
Pacific Biosciences of California Forecast: $2.40 Analyst Target
Direct answer
Pacific Biosciences of California's average price target is $2.40.
The target implies +38.7% from the recorded current price, and the consensus rating is Buy.
The low target implies -27.7%, the high target implies +76.3%, and the range spans 104% of the current price.
Forecast evidence checked October 19, 2026.
Get free Pacific Biosciences of California email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.73
- Average price target
- $2.40
- High price target
- $3.05
- Low price target
- $1.25
- Low target gap
- -27.7%
- Target upside
- +38.7%
- High target gap
- +76.3%
- Target range width
- 104%
- Consensus rating
- Buy
- Analysts
- 7
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is Pacific Biosciences of California's average price target?
Pacific Biosciences of California's verified average price target is $2.40. The target range is $1.25 to $3.05.
How far are Pacific Biosciences of California's low and high targets from the recorded price?
The low target implies -27.7%, while the high target implies +76.3%.
How many analysts are included in Pacific Biosciences of California's consensus?
The verified consensus includes 7 analysts.
How is Pacific Biosciences of California's target upside or downside calculated?
The average target of $2.40 is divided by the recorded price of $1.73, then one is subtracted to produce +38.7%. This does not guarantee a future return.
When was Pacific Biosciences of California's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.